Publikationen

Veröffentlichungen

Björn Bulitta, Werner Zuschratter, Isabel Bernal, Dunja Bruder, Frank Klawonn, Martin von Bergen, Henk Garritsen, Lothar Jänsch.
Proteomic definition of human mucosal‐associated invariant T cells determines their unique molecular effector phenotype.
First published: 11 May 2018
|https://doi.org/10.1002/eji.201747398 European Journal of Immunology

Minoko Takanashi, Eileen Selogie, Jo-Anna Reems, David Stroncek, Megali Fontaine, John Girdlestone, Henk S. P. Garritsen, Pampee Young, David H. McKenna, Zbigniew M. Szczepiorkowski,
Current practices for viability testing of cryopreserved cord blood products: an international survey by the cellular therapy team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. 
*on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative (Transfusion accepted 2018)

Thomas J. Gniadek, Henk S.P. Garritsen, David Stroncek, Zbigniew M. Szczepiorkowski, and David H. McKenna,
Optimal Storage Conditions for Apheresis Research (OSCAR): a Biomedical Excellence for Safer Transfusion (BEST) Collaborative study
on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative*. Transfusion 2018; 58: 2 , 461-469

Michelle P. Zeller, Rebecca Barty, Nancy M. Dunbar, Allahna Elahie, Peter Flanagan, Henk Garritsen, Jose Mauro Kutner, Monica B. Pagano, Ryszard Pogłod, Thomas S. Rogers, Julie Staves, Maria van Wordragen-Vlaswinkel, Jaap Jan Zwaginga,Michael F. Murphy, Nancy M. Heddle, and Mark H. Yazer,
An international investigation into AB plasma administration in hospitals: how many AB plasma units were infused? The HABSWIN study
on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Transfusion 2018; 58:1, 151-157

A.Schulte, H. Garritsen, N. Legath, J.-P. Minol, M. Börgel, S. U. Sixt.
Kryokonservierte Gefäßtransplantate aus humanem Gewebe. der Gefäßchirurg 2017;
6 ,228-236

Michelle Zeller, Rebecca Barty, Astrid Aandahl, Torunn Apelseth, Jeannie Callum, Nancy M. Dunbar, Allahna Elahie, Henk Garritsen, Helen Hancock, José Mauro Kutner, Belinda Manukian, Shuichi Mizuta, Makoto Okuda, Monica B. Pagano, Ryszard Pogłód, Kylie Rushford, Kathleen Selling, Claess Henning Sørensen, Ulrik Sprogøe, Julie Staves, Thorsten Weiland, Silvano Wendel, Erica Wood , Maria van Wordragen, Alyssa Ziman, Jaap Jan Zwaginga, Mike Murphy, Nancy M Heddle, and Mark H. Yazer,
An international investigation into O red blood cell unit administration in hospitals: The GRoup O Utilization Patterns (GROUP) study
on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative. Transfusion 2017;57:10, 2329-2337

A.Chatterjea, V.L.S. LaPointe, A. Baradas, H. Garritsen, H.Yuan, A. Renard, C.A. van Blittterwijk, J.de Boer.
Cell aggregation enhances bone formation by human mesenchymal stromal cells.
(Accepted 2016 eCells Impact 4.9)

Claudia I. Chapuy, Maria D. Aguad, Rachel T. Nicholson, James P. AuBuchon, Claudia S. Cohn, Meghan Delaney, Mark K. Fung, Meredith Unger, Parul D oshi, Michael F. Murphy, Larry J. Dumont, Richard M. Kaufman, and the DARA-DTT Study Group*
International validation of a dithiothreitol (DTT)-based method for negating the daratumumab interference with blood compatibility testing
for the BEST Collaborative Transfusion 2016;56:12, 2964-2972

Cord C. Uphoff, Sandra Lange, Sabine A. Denkmann, Henk S. P.Garritsen, and Hans G. Drexler.
Prevalence and Characterization of Murine Leukemia Virus Contamination in Human Cell Lines
PLOS 2015 apr. 30

Jonas Kügler, Sonja Wilke, Doris Meyer, Florian Tomszak, André Frenzel, Thomas Schirrmann, Henk Garritsen, Stefan Dübel, Björn Hock, Lars Toleikis, Mark Schütte and Michael Hust
Analysis of an improved human antibody phage
display library BMC Biotechnology 2015;15 , 10-18

Pruss A., Garritsen HSP.
Advanced Therapy Medicinal Products - a Multiple Challenge.
Transfus Med Hemother 2013;40:384-385

Henk S. Garritsen, Michael Probst Kepper, Nicole Legath, Wolfgang Eberl, Salome Samaniego, Jannes Woudenberg, Joost H. N. Schuitemaker, David A. Gurney, Gary W. Moore, James L. Zehnder.
High sensitivity & specificity of a new functional flow cytometry assay for clinically significant heparin-induced thrombocytopenia antibodies
Journal of Laboratory Haematology 2014; 36: 2, 135-143

Maxi Scheiter, Ulrike Lau,Marco van Ham, Björn Bulitta,Lothar Gröbe, Henk Garritsen,Frank Klawonn, Sebastian König und Lothar Jänsch.
Proteome Analysis of Distinct Developmental Stages of Human Natural Killer Cells.
Molecular and Cellular Proteomics 2013 may; 12(5): 1099-1114

Derwood Pamphilon, Eileen Selogie,David McKenna, Jose Cancelas-Peres, Zbigniew M. Szczepiorkowski, Ron Sacher, John McMannis, Hermann Eichler, Henk Garritsen, Minoko Takanashi, Leo van de Watering, David Stroncek, Jo-Anna Reems.
Current practices and Prospects for Standardization of the Hematopoietic Colony-Forming-Unit (CFU) assay: A Report by the Cellular Therapy Team of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.
Cytotherapy 2013 mar; 15(3):255-62

Anindita Chatterjea, Huipin Yuan, Supriyo Chatterjea, Henk Garritsen, Auke Renard, Clemens A. van Blitterswijk, Jan de Boer.
A minimally invasive approach to engineering new bone in vivo using human bone marrow derived mesenchymal stromal cells
Tissue Engineering Part A 2013 Feb; 19 (3-4): 340-9

Ana M.C. Barradas, K. Lachmann, Lorenzo Moroni, Cathelijne Frielink, Otto C. Boerman, Henk Garritsen, Kurt Dittmar, Werner Lindenmaier Clemens van Blitterswijk, Jan de Boer
Gas plasma treated polymer enhances osteogenic differentiation of MC3T3
(acta biomaterialia 2012 aug; 8 (8) : 2969-77

Mudita Pincha, Gustavo Salguero, Ralf Gutzmer, Henk Garritsen, Laura Macke, Andreas Schneider, Daniela Lenz, Constanca Figueiredo, Rainer Blasczyk, Eliana Ruggiero, Manfred Schmidt, (Christof von Kalle), Christina Puff, (Wolfgang Baumgaertner), Arnold Ganser, and Renata Stripecke.
Identity, Potency, Safety and GMP Development of Lentiviral Vector-Induced Dendritic Cells for Melanoma Immunotherapy
(Hum Gene Ther Methods. 2012 Feb;23(1):38-55.

Patente

European Patent EP 18162230.9-1118
Verfahren zum Nachweis biogener Amin-Botenstoffe
Neumeier B, Heck J., Feldmann C., Lindermeier, W, Dittmar K, Garritsen H.

European Patent EP 10165451.5
Process for cell cultivation and for cryopreservation
K. Dittmar, H.S.P. Garritsen, W. Lindenmaier, L. Macke

Kongressbeiträge

M Takanashi*, E Selogie, JA Reems, D Stroncek, M Fontaine, J Girdlestone, H Garritsen, P Young, D McKenna, Z Szczepiorkowski.
Poster + Vortrag
ISBT Toronto 2-6 june 2018

Garritsen H.S.P.
MALDI-TOF als Methode im transfusionsmedizinische Labor Vortrag
DGTI Meeting Köln, 25.10.2017

Henk Garritsen
"Nanoparticles and allergy diagnostics". Vortrag
18.05.2017 Biozentrum der TU-Braunschweig

Garritsen H.S.P.
DC Generation: immunomagnetic vs. Elutriation, an update Vortrag
BEST Meeting sydney, australien, April 27-28, 2017

Michelle Zeller, Astrid Aandahl, Torunn Apelseth, Jeannie Callum, Nancy M. Dunbar, Henk Garritsen, Helen Hancock, José Mauro Kutner, Belinda Manukian, Shuichi Mizuta, Makoto Okuda, Monica B. Pagano, Ryszard Poglód, Kylie Rushford, Kathleen Selling, Claess Henning Sørensen, Ulrik Sprogøe, Julie Staves, Maria van Wordragen, Thorsten Weiland, Silvano Wendel, Alyssa Ziman, Nancy M Heddle, Mark H. Yazer,
on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative‚
GRoup O Utilization Patterns: The GROUP study’ Vortrag
AABB Orlando Florida 23-27.10.2016

Michelle P Zeller, Julie Staves, Peter Flanagan, Nancy Dunbar, José Mauro Kutner, Henk Garritsen, Allahna Elahie, Thomas Rogers, Thomas Rogers, Rinie van Wordragen, Monica Pagano, Rebecca Barty, Nancy M Heddle, Mark Yazer
on behalf of the Biomedical Excellence for Safer Transfusion (BEST) Collaborative
How many AB plaSma units Were INfused? The HABSWIN study Vortrag
AABB Orlando Florida 23-27.10.2016

Garritsen H.S.P.
DC Generation: immunomagnetic vs. Elutriation, an update Vortrag
BEST Meeting Oxford, UK, 14-16.04.2016

Garritsen, H.S.P.
GMP-gerechte Herstellung zellulärer Arzneimittel am Städtischen Klinikum Braunschweig: Darf es ein bisschen mehr sein? Vortrag
Deutsche Pharmazeutische Gesellschaft. Technische Universität Braunschweig, Fakultät der Pharmazie, Braunschweig, 07.01.2016

Garritsen, H.S.P.
Cells meet Plasma: Wellness im Zellkulturbeutel Vortrag
Kompetenznetz INPLAS Braunschweig 12.06.2015

Garritsen H.S.P.
Leukapherese- Wie isolieren wir immunkompetente Zellen Vortrag
Uro-Onkologischen Fortbildung Blasen- und Prostatakarzinome 2014,Braunschweig 12.11.2014

Garritsen H.S.P.
Non-radioactive Platelet survival measurements using MtDNA Vortrag
BEST Meeting philadelfia, USA, 22-23.10.2014

Dr. M. Thomas, Dr. K. Lachmann, Dr. H. Garritsen, Dr. W Lindenmaier, Dr. K. Dittmar.
Plasma in a bag – Coatings for cell cultivation Vortrag
Stem cell Meeting Leipzig Oktober 2014

Garritsen, H.S.P.
Neue Wege in der Krebstherapie: Tumor-Vakzinierung mit dendritischen Zellen Vortrag
Frühjahrstagung der Biotechnologen DECHEMA Frankfurt 11.03.2014

Garritsen, H.S.P.
Viren in der Transplantations-,Transfusions- und Reisemedizin Vortrag
Ringvorlesung Virologie Technische Universität Braunschweig, Braunschweig, 22.01.2014

Garritsen H.S.P.
HIT-neue Möglichkeiten der funktionelle Diagnostik Vortrag
Veranstaltung Perioperatives Gerinnungsmanagement :n eine interdiziplinäre Aufgabe Braunschweig 29.08.2013